Membranous nephropathy treatable with RituximabRituximab can prove to be an effective form of treatment when it comes to providing relief to patients suffering from membranous nephropathy, a kidney disorder.

This finding appeared in an issue of the Clinical Journal of the American Society of Nephrology (CJASN).

The beneficial effect of Rituximab was compared against nephropathy in terms of benefits during a systematic review conducted by Andrew Bomback, MD (University of North Carolina Kidney Center), and his colleagues.

It was remarked by Dr. Bomback that future studies would be crucial in ascertaining the true value of this drug and use of the drug must be made in research settings only till new studies are drawn.